Prevalence of treatment resistance and clozapine use in early intervention services

BACKGROUND: Treatment resistance causes significant burden in psychosis. Clozapine is the only evidence-based pharmacologic intervention available for people with treatment-resistant schizophrenia; current guidelines recommend commencement after two unsuccessful trials of standard antipsychotics. AI...

Descripción completa

Detalles Bibliográficos
Autores principales: Stokes, Imogen, Griffiths, Siân Lowri, Jones, Rowena, Everard, Linda, Jones, Peter B., Fowler, David, Hodgekins, Joanne, Amos, Tim, Freemantle, Nick, Sharma, Vimal, Marshall, Max, Singh, Swaran P., Birchwood, Max, Upthegrove, Rachel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576650/
https://www.ncbi.nlm.nih.gov/pubmed/32938513
http://dx.doi.org/10.1192/bjo.2020.89

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576650/
https://www.ncbi.nlm.nih.gov/pubmed/32938513
http://dx.doi.org/10.1192/bjo.2020.89

Ejemplares similares